ARTICLE | Company News
Celera, Medical Therapies deal
November 9, 2009 8:00 AM UTC
Celera received an exclusive, worldwide license to Medical Therapies' midkine patent portfolio to develop and commercialize lung cancer diagnostics. Midkine is a heparin-binding growth factor. Medical...